A Four-kallikrein Panel Predicts High-grade Cancer on Biopsy: Independent Validation in a Community Cohort.

Summary, in English

A statistical model based on four kallikrein markers (total prostate-specific antigen [tPSA], free PSA [fPSA], intact PSA, and human kallikrein-related peptidase 2) in blood can predict risk of Gleason score ≥7 (high-grade) cancer at prostate biopsy.

• Författare: Katharina Braun; Daniel D Sjoberg; Andrew J Vickers; Hans Lilja; Anders Bjartell
• Avdelning/ar: Klinisk kemi, Malmö; BioCARE: Biomarkers in Cancer Medicine improving Health Care, Education and Innovation; Urologisk cancerforskning, Malmö; EpiHealth: Epidemiology for Health
• Publiceringsår: 2015-05-12
• Språk: Engelska
• Publikation/Tidskrift/Serie: European Urology
• Länkar: http://www.ncbi.nlm.nih.gov/pubmed/25979570?dopt=Abstract; http://dx.doi.org/10.1016/j.eururo.2015.04.028
• Dokumenttyp: Artikel i tidskrift
• Förlag: Elsevier
• Ämne: Urology and Nephrology
• Status: Published
• Forskningsgrupp: Clinical Chemistry, Malmö; Urological cancer, Malmö
• ISBN/ISSN/Övrigt: ISSN: 1873-7560